Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Bio Similars/Subsequent Entry Biologic market report explains the definition, types, applications, major countries, and major players of the Bio Similars/Subsequent Entry Biologic market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Johnson & Johnson
Novo Nordisk
Dong Bao
Gelgen
Synthon Pharmaceuticals
3sbio
Sun Pharma
Genentech (Roche)
Stada Arzneimittel AG
Teva Pharmaceutical Industries
Novartis
Celltrion Biocon
Ganlee
Biotech
Celltrion
Innovent
Pfizer
AbbVie
Biocon
Samsung Biologics
Sanofi-Aventis
Amgen
Eli Lilly
Hospira
Merck
Dr Reddy's Laboratories
LG Life Sciences
Biogen idec
Mylan
By Type:
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other
By End-User:
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Bio Similars/Subsequent Entry Biologic Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Bio Similars/Subsequent Entry Biologic Outlook to 2028- Original Forecasts
-
2.2 Bio Similars/Subsequent Entry Biologic Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Bio Similars/Subsequent Entry Biologic Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Bio Similars/Subsequent Entry Biologic Market- Recent Developments
-
6.1 Bio Similars/Subsequent Entry Biologic Market News and Developments
-
6.2 Bio Similars/Subsequent Entry Biologic Market Deals Landscape
7 Bio Similars/Subsequent Entry Biologic Raw Materials and Cost Structure Analysis
-
7.1 Bio Similars/Subsequent Entry Biologic Key Raw Materials
-
7.2 Bio Similars/Subsequent Entry Biologic Price Trend of Key Raw Materials
-
7.3 Bio Similars/Subsequent Entry Biologic Key Suppliers of Raw Materials
-
7.4 Bio Similars/Subsequent Entry Biologic Market Concentration Rate of Raw Materials
-
7.5 Bio Similars/Subsequent Entry Biologic Cost Structure Analysis
-
7.5.1 Bio Similars/Subsequent Entry Biologic Raw Materials Analysis
-
7.5.2 Bio Similars/Subsequent Entry Biologic Labor Cost Analysis
-
7.5.3 Bio Similars/Subsequent Entry Biologic Manufacturing Expenses Analysis
8 Global Bio Similars/Subsequent Entry Biologic Import and Export Analysis (Top 10 Countries)
-
8.1 Global Bio Similars/Subsequent Entry Biologic Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Bio Similars/Subsequent Entry Biologic Export by Region (Top 10 Countries) (2017-2028)
9 Global Bio Similars/Subsequent Entry Biologic Market Outlook by Types and Applications to 2022
-
9.1 Global Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Interferon Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Erythropoietin Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Insulin Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Vaccines Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Tumor Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Cardiovascular Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Hemophilia Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Bio Similars/Subsequent Entry Biologic Market Analysis and Outlook till 2022
-
10.1 Global Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.2.2 Canada Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.2.3 Mexico Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.3.2 UK Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.3.3 Spain Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.3.4 Belgium Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.3.5 France Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.3.6 Italy Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.3.7 Denmark Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.3.8 Finland Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.3.9 Norway Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.3.10 Sweden Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.3.11 Poland Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.3.12 Russia Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.3.13 Turkey Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.4.2 Japan Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.4.3 India Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.4.4 South Korea Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.4.5 Pakistan Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.4.6 Bangladesh Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.4.7 Indonesia Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.4.8 Thailand Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.4.9 Singapore Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.4.10 Malaysia Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.4.11 Philippines Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.4.12 Vietnam Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.5.2 Colombia Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.5.3 Chile Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.5.4 Argentina Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.5.5 Venezuela Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.5.6 Peru Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.5.7 Puerto Rico Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.5.8 Ecuador Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.6.2 Kuwait Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.6.3 Oman Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.6.4 Qatar Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.6.5 Saudi Arabia Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.6.6 United Arab Emirates Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.7.2 South Africa Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.7.3 Egypt Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.7.4 Algeria Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
-
10.8.2 New Zealand Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)
11 Global Bio Similars/Subsequent Entry Biologic Competitive Analysis
-
11.1 Johnson & Johnson
-
11.1.1 Johnson & Johnson Company Details
-
11.1.2 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.1.4 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Novo Nordisk
-
11.2.1 Novo Nordisk Company Details
-
11.2.2 Novo Nordisk Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Novo Nordisk Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.2.4 Novo Nordisk Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Dong Bao
-
11.3.1 Dong Bao Company Details
-
11.3.2 Dong Bao Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Dong Bao Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.3.4 Dong Bao Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Gelgen
-
11.4.1 Gelgen Company Details
-
11.4.2 Gelgen Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Gelgen Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.4.4 Gelgen Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Synthon Pharmaceuticals
-
11.5.1 Synthon Pharmaceuticals Company Details
-
11.5.2 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.5.4 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 3sbio
-
11.6.1 3sbio Company Details
-
11.6.2 3sbio Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 3sbio Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.6.4 3sbio Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Sun Pharma
-
11.7.1 Sun Pharma Company Details
-
11.7.2 Sun Pharma Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Sun Pharma Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.7.4 Sun Pharma Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Genentech (Roche)
-
11.8.1 Genentech (Roche) Company Details
-
11.8.2 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.8.4 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Stada Arzneimittel AG
-
11.9.1 Stada Arzneimittel AG Company Details
-
11.9.2 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.9.4 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Teva Pharmaceutical Industries
-
11.10.1 Teva Pharmaceutical Industries Company Details
-
11.10.2 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.10.4 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Novartis
-
11.11.1 Novartis Company Details
-
11.11.2 Novartis Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Novartis Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.11.4 Novartis Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Celltrion Biocon
-
11.12.1 Celltrion Biocon Company Details
-
11.12.2 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.12.4 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Ganlee
-
11.13.1 Ganlee Company Details
-
11.13.2 Ganlee Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Ganlee Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.13.4 Ganlee Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Biotech
-
11.14.1 Biotech Company Details
-
11.14.2 Biotech Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Biotech Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.14.4 Biotech Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Celltrion
-
11.15.1 Celltrion Company Details
-
11.15.2 Celltrion Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Celltrion Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.15.4 Celltrion Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Innovent
-
11.16.1 Innovent Company Details
-
11.16.2 Innovent Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Innovent Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.16.4 Innovent Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Pfizer
-
11.17.1 Pfizer Company Details
-
11.17.2 Pfizer Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Pfizer Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.17.4 Pfizer Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 AbbVie
-
11.18.1 AbbVie Company Details
-
11.18.2 AbbVie Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 AbbVie Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.18.4 AbbVie Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Biocon
-
11.19.1 Biocon Company Details
-
11.19.2 Biocon Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Biocon Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.19.4 Biocon Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Samsung Biologics
-
11.20.1 Samsung Biologics Company Details
-
11.20.2 Samsung Biologics Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Samsung Biologics Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.20.4 Samsung Biologics Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.20.5 Recent Research and Development Strategies
-
11.21 Sanofi-Aventis
-
11.21.1 Sanofi-Aventis Company Details
-
11.21.2 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.21.3 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.21.4 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.21.5 Recent Research and Development Strategies
-
11.22 Amgen
-
11.22.1 Amgen Company Details
-
11.22.2 Amgen Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.22.3 Amgen Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.22.4 Amgen Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.22.5 Recent Research and Development Strategies
-
11.23 Eli Lilly
-
11.23.1 Eli Lilly Company Details
-
11.23.2 Eli Lilly Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.23.3 Eli Lilly Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.23.4 Eli Lilly Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.23.5 Recent Research and Development Strategies
-
11.24 Hospira
-
11.24.1 Hospira Company Details
-
11.24.2 Hospira Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.24.3 Hospira Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.24.4 Hospira Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.24.5 Recent Research and Development Strategies
-
11.25 Merck
-
11.25.1 Merck Company Details
-
11.25.2 Merck Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.25.3 Merck Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.25.4 Merck Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.25.5 Recent Research and Development Strategies
-
11.26 Dr Reddy's Laboratories
-
11.26.1 Dr Reddy's Laboratories Company Details
-
11.26.2 Dr Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.26.3 Dr Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.26.4 Dr Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.26.5 Recent Research and Development Strategies
-
11.27 LG Life Sciences
-
11.27.1 LG Life Sciences Company Details
-
11.27.2 LG Life Sciences Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.27.3 LG Life Sciences Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.27.4 LG Life Sciences Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.27.5 Recent Research and Development Strategies
-
11.28 Biogen idec
-
11.28.1 Biogen idec Company Details
-
11.28.2 Biogen idec Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.28.3 Biogen idec Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.28.4 Biogen idec Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.28.5 Recent Research and Development Strategies
-
11.29 Mylan
-
11.29.1 Mylan Company Details
-
11.29.2 Mylan Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
11.29.3 Mylan Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
11.29.4 Mylan Bio Similars/Subsequent Entry Biologic Product Portfolio
-
11.29.5 Recent Research and Development Strategies
12 Global Bio Similars/Subsequent Entry Biologic Market Outlook by Types and Applications to 2028
-
12.1 Global Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Interferon Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Erythropoietin Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Insulin Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Tumor Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Hemophilia Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Bio Similars/Subsequent Entry Biologic Market Analysis and Outlook to 2028
-
13.1 Global Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.2.2 Canada Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.2.3 Mexico Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.3.2 UK Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.3.3 Spain Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.3.4 Belgium Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.3.5 France Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.3.6 Italy Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.3.7 Denmark Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.3.8 Finland Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.3.9 Norway Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.3.10 Sweden Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.3.11 Poland Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.3.12 Russia Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.3.13 Turkey Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.4.2 Japan Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.4.3 India Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.4.4 South Korea Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.4.8 Thailand Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.4.9 Singapore Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.4.11 Philippines Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.5.2 Colombia Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.5.3 Chile Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.5.4 Argentina Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.5.6 Peru Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.6.3 Oman Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.6.4 Qatar Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.7.2 South Africa Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.7.3 Egypt Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.7.4 Algeria Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Bio Similars/Subsequent Entry Biologic
-
Figure of Bio Similars/Subsequent Entry Biologic Picture
-
Table Global Bio Similars/Subsequent Entry Biologic Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Bio Similars/Subsequent Entry Biologic Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Interferon Consumption and Growth Rate (2017-2022)
-
Figure Global Erythropoietin Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Tumor Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Consumption and Growth Rate (2017-2022)
-
Figure Global Hemophilia Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Bio Similars/Subsequent Entry Biologic Consumption by Country (2017-2022)
-
Table North America Bio Similars/Subsequent Entry Biologic Consumption by Country (2017-2022)
-
Figure United States Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Canada Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Mexico Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Table Europe Bio Similars/Subsequent Entry Biologic Consumption by Country (2017-2022)
-
Figure Germany Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure UK Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Spain Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Belgium Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure France Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Italy Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Denmark Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Finland Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Norway Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Sweden Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Poland Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Russia Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Turkey Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Table APAC Bio Similars/Subsequent Entry Biologic Consumption by Country (2017-2022)
-
Figure China Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Japan Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure India Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure South Korea Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Thailand Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Singapore Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Philippines Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Table South America Bio Similars/Subsequent Entry Biologic Consumption by Country (2017-2022)
-
Figure Brazil Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Colombia Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Chile Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Argentina Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Peru Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Table GCC Bio Similars/Subsequent Entry Biologic Consumption by Country (2017-2022)
-
Figure Bahrain Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Oman Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Qatar Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Table Africa Bio Similars/Subsequent Entry Biologic Consumption by Country (2017-2022)
-
Figure Nigeria Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure South Africa Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Egypt Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure Algeria Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Table Oceania Bio Similars/Subsequent Entry Biologic Consumption by Country (2017-2022)
-
Figure Australia Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Johnson & Johnson Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Novo Nordisk Company Details
-
Table Novo Nordisk Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Novo Nordisk Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Dong Bao Company Details
-
Table Dong Bao Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dong Bao Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Dong Bao Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Gelgen Company Details
-
Table Gelgen Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gelgen Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Gelgen Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Synthon Pharmaceuticals Company Details
-
Table Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table 3sbio Company Details
-
Table 3sbio Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table 3sbio Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table 3sbio Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Sun Pharma Company Details
-
Table Sun Pharma Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharma Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Sun Pharma Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Genentech (Roche) Company Details
-
Table Genentech (Roche) Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech (Roche) Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Genentech (Roche) Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Stada Arzneimittel AG Company Details
-
Table Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Teva Pharmaceutical Industries Company Details
-
Table Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Novartis Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Celltrion Biocon Company Details
-
Table Celltrion Biocon Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celltrion Biocon Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Celltrion Biocon Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Ganlee Company Details
-
Table Ganlee Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ganlee Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Ganlee Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Biotech Company Details
-
Table Biotech Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biotech Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Biotech Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Celltrion Company Details
-
Table Celltrion Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celltrion Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Celltrion Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Innovent Company Details
-
Table Innovent Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Innovent Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Innovent Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Pfizer Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table AbbVie Company Details
-
Table AbbVie Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table AbbVie Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Biocon Company Details
-
Table Biocon Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Biocon Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Samsung Biologics Company Details
-
Table Samsung Biologics Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Samsung Biologics Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Samsung Biologics Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Sanofi-Aventis Company Details
-
Table Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Amgen Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Eli Lilly Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Hospira Company Details
-
Table Hospira Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hospira Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Hospira Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Merck Company Details
-
Table Merck Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Merck Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Dr Reddy's Laboratories Company Details
-
Table Dr Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Dr Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table LG Life Sciences Company Details
-
Table LG Life Sciences Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table LG Life Sciences Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table LG Life Sciences Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Biogen idec Company Details
-
Table Biogen idec Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen idec Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Biogen idec Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Table Mylan Company Details
-
Table Mylan Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Bio Similars/Subsequent Entry Biologic Main Business and Markets Served
-
Table Mylan Bio Similars/Subsequent Entry Biologic Product Portfolio
-
Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interferon Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Erythropoietin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tumor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hemophilia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bio Similars/Subsequent Entry Biologic Consumption Forecast by Country (2022-2028)
-
Table North America Bio Similars/Subsequent Entry Biologic Consumption Forecast by Country (2022-2028)
-
Figure United States Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Bio Similars/Subsequent Entry Biologic Consumption Forecast by Country (2022-2028)
-
Figure Germany Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Bio Similars/Subsequent Entry Biologic Consumption Forecast by Country (2022-2028)
-
Figure China Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Bio Similars/Subsequent Entry Biologic Consumption Forecast by Country (2022-2028)
-
Figure Brazil Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Bio Similars/Subsequent Entry Biologic Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Bio Similars/Subsequent Entry Biologic Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Bio Similars/Subsequent Entry Biologic Consumption Forecast by Country (2022-2028)
-
Figure Australia Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)
-
